EMERSON PERIN to Genetic Therapy
This is a "connection" page, showing publications EMERSON PERIN has written about Genetic Therapy.
Connection Strength
0.482
-
Human hepatocyte growth factor (VM202) gene therapy via transendocardial injection in a pig model of chronic myocardial ischemia. J Card Fail. 2011 Jul; 17(7):601-11.
Score: 0.262
-
Gene therapy for diabetic foot ulcers: Interim analysis of a randomised, placebo-controlled phase 3 study of VM202 (ENGENSIS), a plasmid DNA expressing two isoforms of human hepatocyte growth factor. Int Wound J. 2023 Nov; 20(9):3531-3539.
Score: 0.151
-
Gene Therapy Knockdown of Hippo Signaling Resolves Arrhythmic Events in Pigs After Myocardial Infarction. Circulation. 2022 11 15; 146(20):1558-1560.
Score: 0.036
-
Gene therapy knockdown of Hippo signaling induces cardiomyocyte renewal in pigs after myocardial infarction. Sci Transl Med. 2021 06 30; 13(600).
Score: 0.033